Orris

Fibrinogen 96 tpc-18 pt-12 Suspecting dic what should be the management criteria

Reading File
Finding Sources
Finding Sources
Searching PubMed

"Disseminated Intravascular Coagulation"[MeSH Terms]

Searching the Web

ISTH guidance disseminated intravascular coagulation management fibrinogen platelet transfusion threshold

Fibrinogen 96 mg/dL (0.96 g/L) with platelet count about 18,000/µL is dangerously low and needs urgent hospital/ICU-level assessment, particularly if there is bleeding, sepsis, obstetric hemorrhage, trauma, malignancy, shock, or organ dysfunction.
A PT of 12 seconds may be normal depending on the laboratory reference range. Obtain the INR, aPTT, D-dimer/FDP, repeat platelet count and fibrinogen serially, plus renal/liver tests, blood film, lactate, hemolysis tests, and cultures if infection is possible. DIC is a clinical-laboratory syndrome, so use an ISTH overt-DIC score and reassess trends rather than relying on one result.

Immediate management priorities

  1. Treat the trigger immediately
    • Sepsis: cultures, antibiotics, source control, resuscitation.
    • Obstetric cause: activate major-obstetric-hemorrhage protocol and control hemorrhage.
    • Trauma/surgery: control bleeding.
    • Malignancy, especially APL: urgent hematology input and disease-specific treatment.
    • This is the main treatment for DIC.
  2. If active bleeding, severe coagulopathy, or an urgent invasive procedure
    • Fibrinogen replacement now: give cryoprecipitate or fibrinogen concentrate.
      • Fibrinogen 96 mg/dL is below the usual treatment threshold of 100 mg/dL in bleeding DIC.
      • Target generally >150 mg/dL.
      • In obstetric hemorrhage, many protocols target >200 mg/dL.
      • Recheck fibrinogen after replacement and repeat as needed.
    • Platelets:
      • With active bleeding or a procedure, transfuse when platelets are <50,000/µL. A count around 18,000/µL warrants platelet support in this setting.
      • If not bleeding and no procedure is planned, platelet transfusion is individualized; it is generally considered at very low counts such as <10,000/µL, or at higher thresholds if bleeding risk is high. Discuss urgently with hematology/critical care.
    • Fresh frozen plasma (FFP):
      • Give if there is active bleeding/procedure and PT/aPTT is significantly prolonged from factor depletion.
      • Do not give FFP solely to normalize an abnormal lab value in a stable, non-bleeding patient.
    • Red cells as clinically indicated, using a major hemorrhage protocol if bleeding is ongoing.
  3. Avoid routine anticoagulation in a bleeding patient
    • Heparin is not routine for consumptive, bleeding DIC.
    • Consider therapeutic anticoagulation only if thrombosis predominates, such as documented VTE, purpura fulminans, or acral ischemia, and only with hematology/ICU guidance.
  4. Monitoring
    • Admit and monitor vitals, urine output, mental status, bleeding, thrombosis, and organ dysfunction.
    • Repeat CBC, PT/INR, aPTT, fibrinogen, and D-dimer frequently, often every 4-6 hours during active deterioration/hemorrhage.
    • Avoid IM injections, unnecessary venepunctures, and antiplatelet/NSAID drugs.
Practical interpretation: if this patient has bleeding or needs a procedure, the combination of fibrinogen 96 and platelets 18k supports immediate cryo/fibrinogen replacement plus platelet transfusion, while urgently finding and treating the cause. Get senior hematology, ICU, anesthesia, or obstetric support now depending on the setting.
Recent DIC guidance is summarized in the 2024 Japanese DIC guideline series, and emergency-text guidance supports platelets for active bleeding with counts below 50,000/µL and plasma/fibrinogen replacement when fibrinogen is below 100 mg/dL with bleeding.
This is a shared conversation. Sign in to Orris to start your own chat.